ArticleScientific reports2026
Deep learning driven early detection of lung cancer from CT images using transfer learning approaches.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lung cancer remains one of the foremost causes of cancer-related mortality worldwide, primarily due to its frequent late-stage diagnosis and the limited efficacy of available treatments at advanced stages. This study seeks to advance early detection through the application of deep learning techniques for the automated classification of lung CT images into benign, malignant, and normal categories. A comprehensive methodological framework was adopted, encompassing data acquisition, preprocessing, model development, training, validation, and performance evaluation, with patient-level data splitting employed to prevent slice-level data leakage. Among six tested architectures (VGG16, Custom CNN, MobileNetV2, ResNet50, InceptionV3, and EfficientNetB0), the fully fine-tuned VGG16 model optimized via transfer learning and trained on the IQ-OTH/NCCD lung cancer dataset exhibited the strongest overall performance, achieving a mean test accuracy of 89.39% ± 2.10% (test loss 0.329) across three independent runs, and 89.70% ± 2.75% under 5-fold patient-grouped cross-validation. One-way ANOVA (F = 17.55, p < 0.0001) followed by Tukey's HSD post-hoc test confirmed that VGG16 significantly outperformed ResNet50 and EfficientNetB0. To enhance interpretability, Grad-CAM visualizations were generated for all three classes, indicating that the model's attention broadly corresponded to anatomically relevant lung regions. Trained and evaluated on a Google Colab GPU environment, the proposed system demonstrates potential as an assistive tool for automated lung cancer screening, warranting further validation on larger and multi-institutional datasets before clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.